Earnings
ARWR
81.14
-3.55%
-2.99
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-09-30
143.58M
171.91M
--
845.67K
--
--
0.00
--
--
--
4.25M
1.78M
322.37M
47.02M
--
137.49M
--
--
15.36M
--
265.36K
200.13M
522.50M
--
6.83M
0.00
--
--
--
--
--
14.54M
--
--
--
19.31M
40.68M
0.00
--
--
--
20.04M
20.04M
60.72M
194.75K
965.41M
-503.84M
--
--
0.00
461.78M
461.78M
522.50M
FY 2019-09-30
221.80M
36.90M
--
661.36K
--
--
0.00
--
--
--
3.32M
2.56M
265.25M
23.21M
--
44.18M
--
--
17.06M
--
144.15K
84.60M
349.85M
--
7.65M
0.00
--
--
--
--
--
11.46M
--
--
--
77.96M
97.07M
0.00
--
--
--
8.74M
8.18M
105.81M
187.88K
664.09M
-419.29M
--
--
-555.19K
244.59M
244.04M
349.85M
FY 2018-09-30
30.13M
46.40M
--
327.38K
--
--
0.00
--
--
--
1.27M
640.12K
78.77M
13.94M
--
--
--
--
18.76M
--
141.92K
32.84M
111.61M
--
2.81M
0.00
--
--
--
--
--
8.98M
--
--
--
354.34K
12.36M
2.10M
--
--
--
1.90M
3.45M
16.37M
180.88K
582.90M
-487.27M
--
--
-555.19K
95.80M
95.24M
111.61M
FY 2017-09-30
24.84M
40.77M
--
67.80K
--
--
0.00
--
--
--
867.36K
1.36M
67.90M
15.51M
--
--
--
--
20.46M
--
141.92K
36.12M
104.02M
--
4.08M
0.00
--
--
--
--
--
7.96M
--
--
--
6.45M
18.70M
2.33M
--
--
--
2.13M
3.90M
23.16M
167.16K
514.04M
-432.82M
--
--
-555.19K
81.42M
80.87M
104.02M
FY 2016-09-30
85.37M
0.00
--
75.00K
--
--
0.00
--
--
--
1.29M
3.77M
90.50M
15.39M
--
--
--
--
22.16M
--
122.33K
37.67M
128.18M
--
12.23M
0.00
--
--
--
--
--
8.56M
--
--
--
4.66M
25.64M
2.53M
--
--
--
4.97M
6.95M
33.15M
162.12K
493.84M
-398.44M
--
--
-555.19K
95.58M
95.02M
128.18M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ARWR latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Arrowhead Pharms recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.